Article Details

Nilo Therapeutics | The Pharmaletter

Retrieved on: 2025-10-11 17:10:33

Tags for this article:

Click the tags to see associated articles and topics

Nilo Therapeutics | The Pharmaletter. View article details on hiswai:

Excerpt

In October 2025, Nilo launched publicly with a $101 million Series A financing, led by The Column Group, DCVC Bio, and Lux Capital, with participation ...

Article found on: www.thepharmaletter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo